Jill Wechsler is ACT's Washington Correspondent

Articles

Agency releases a series of new guidances to advance the reliability of patient-focused tools and methods.

FDA Expands Patient Input on Drug Development

Robert Foster, CEO of Hepion Pharmaceuticals, discusses strategies for being competitive in the current economic environment.

Start-Up Pharma Weathering the Inflation

Seek pared-down measure in funding bill to avert shutdown.

Congress Slated to Reauthorize User Fees, Without FDA ‘Improvements’ 

Barbara Lopez Kunz, president, and global chief executive at DIA, discusses key themes on the current state of the clinical trials industry and its future.

Key Clinical Trial Industry Themes Post-COVID

Agency officials express associated concerns around clinical trial data reliability and quality.

Clinical Trial Modernization Raises FDA Compliance Issues

Raj Indupuri from eClinical Solutions and Douglas Barta from Cerevel Therapeutics discuss how a digital clinical architecture is ideal for modern researchers and trials.

Digital Clinical Architecture for Modern Researchers

Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Proposed US merger could threaten innovation in cancer diagnosis, Commission officials assert.

Europe Digs in Its Heels Over Cancer Testing Competition

CEO, Sickle Cell Reproductive Health Education Directive

Decentralized trials provide promise for lowering barriers in participation, but industry must continue to be proactive in patient centricity.

Making Clinical Research More Equitable Makes for More Effective Medications

Danielle Mitchell, Founder of Black Women in Clinical Research, discusses how her foundation bridges the gap between minority professionals and clinical trials.

Blogs